Form 4: Halozyme Therapeutics CEO Helen Torley Gifts 10,000 Shares to Charity
SEC Form 4 Filing
Halozyme Therapeutics CEO Helen Torley gifted 10,000 shares of common stock to charity on November 29, 2024.
Summary
- Halozyme Therapeutics CEO, Helen Torley, has reported a transaction involving the gifting of 10,000 common stock shares.
- The transaction occurred on November 29, 2024.
- The shares were gifted to charity and had a value of $0 at the time of the transaction.
- Following the transaction, Ms. Torley directly owns 666,744 shares of Halozyme Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document is a neutral report of a stock transaction, with no positive or negative implications for the company's performance.
Industry Context
This is a routine filing related to insider transactions and is not indicative of any broader industry trends.
Comparison to Industry Standards
- Executive stock transactions are common across the industry, and this gift is not unusual.
- Many executives use stock gifts to charities as part of their financial planning.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a gift of shares by an executive.
Key Dates
| Date | Description |
|---|---|
| 11/29/2024 | Date of the stock gift transaction. |
| 12/03/2024 | Date the SEC Form 4 was signed. |
Keywords
Halozyme Therapeutics, Helen Torley, stock gift, charity, insider transaction, SEC Form 4, executive stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.